ArticleCancers2021

Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer.

Esther N Pijnappel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.